TFRC and Alzheimer disease: In the context of liquid biopsy, biomarkers reflecting peripheral iron homeostasis—such as CSF ferritin and the serum sTfR/ferritin ratio—have demonstrated high sensitivity and specificity in distinguishing mild cognitive impairment (MCI) from AD (Du et al., 2024).